- CRISPR Patents: Aspiring to Coherent Patent Policy.Robert Cook-Deegan - 2018 - American Journal of Bioethics 18 (12):51-54.details
|
|
Explaining the move toward the market in US academic science: how institutional logics can change without institutional entrepreneurs.Elizabeth Popp Berman - 2012 - Theory and Society 41 (3):261-299.details
|
|
(1 other version)Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980. [REVIEW]Doogab Yi - 2008 - Journal of the History of Biology 41 (4):589 - 636.details
|
|
Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.Oliver Feeney, Julian Cockbain, Michael Morrison, Lisa Diependaele, Kristof Van Assche & Sigrid Sterckx - 2018 - American Journal of Bioethics 18 (12):36-48.details
|
|
Cuts and the cutting edge: British science funding and the making of animal biotechnology in 1980s Edinburgh.Dmitriy Myelnikov - 2017 - British Journal for the History of Science 50 (4):701-728.details
|
|
Who Owns What? Private Ownership and the Public Interest in Recombinant DNA Technology in the 1970s.Doogab Yi - 2011 - Isis 102 (3):446-474.details
|
|
(1 other version)Cancer, Viruses, and Mass Migration: Paul Berg’s Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967–1980.Doogab Yi - 2008 - Journal of the History of Biology 41 (4):589-636.details
|
|
Equitable Access to Human Biological Resources in Developing Countries: Benefit Sharing Without Undue Inducement.Roger Scarlin Chennells - 2015 - Cham: Imprint: Springer.details
|
|
Towards a hermeneutic of technomedical objects.Kjetil Rommetveit - 2008 - Theoretical Medicine and Bioethics 29 (2):103-120.details
|
|
The Patenting of Biological Materials in the United States: A State of Policy Confusion.Luigi Palombi - 2015 - Perspectives on Science 23 (1):35-65.details
|
|
Antibiotic Resistance and the Biology of History.Hannah Landecker - 2016 - Body and Society 22 (4):19-52.details
|
|
The Bermuda Triangle: The Pragmatics, Policies, and Principles for Data Sharing in the History of the Human Genome Project.Kathryn Maxson Jones, Rachel A. Ankeny & Robert Cook-Deegan - 2018 - Journal of the History of Biology 51 (4):693-805.details
|
|
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968–2000.Farah Huzair & Steve Sturdy - 2017 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 64:11-21.details
|
|
Proliferating patent problems with human embryonic stem cell research?Matthew Herder - 2006 - Journal of Bioethical Inquiry 3 (1-2):69-79.details
|
|
Ethics in the societal debate on genetically modified organisms: A (re)quest for sense and sensibility. [REVIEW]Yann Devos, Pieter Maeseele, Dirk Reheul, Linda Van Speybroeck & Danny De Waele - 2008 - Journal of Agricultural and Environmental Ethics 21 (1):29-61.details
|
|
(2 other versions)Adaptation or selection? Old issues and new stakes in the postwar debates over bacterial drug resistance.Angela N. H. Creager - 2007 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 38 (1):159-190.details
|
|
(2 other versions)Adaptation or selection? Old issues and new stakes in the postwar debates over bacterial drug resistance.Angela N. H. Creager - 2007 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 38 (1):159-190.details
|
|